title: Effects of telemedicine in the treatment of patients with type 2 diabetes--a study protocol.
abstract: BACKGROUND
  Despite rehabilitation programmes offered to all patients with newly diagnosed type 2 diabetes in Denmark, a number of patients either never accomplish good diabetes regulation or the regulation deteriorates with time. Therefore, new approaches are needed. The aim of the present study is to examine whether telemedicine conferences with a nurse can contribute to achieving good diabetes control among patients with poorly regulated type 2 diabetes.
  
  
  METHODS
  A total of 165 patients with type 2 diabetes who have formerly undergone a rehabilitation programme are randomized to either telemedicine intervention or usual care. The intervention lasts for 32 weeks and consists of monthly videoconferences with a nurse from a health-care centre as an add-on to usual care. Blood sugar, blood pressure and weight are regularly self-monitored and measurements are automatically transferred to a database. Glycaemic control (HbA1c level) is examined at baseline, 16 weeks, 32 weeks and 58 weeks (six months post intervention). Blood pressure, weight, waist/hip ratio, quality of life, physical activity, lipids, creatinine and haemoglobin are examined at baseline and after 32 weeks.
  
  
  CONCLUSIONS
  The study will examine whether telemedicine technology can contribute to achieving good diabetes regulation.
  
  
  BACKGROUND
  The City of Copenhagen and the Prevention Fund of the Capital Region of Denmark funded the project. Also "Smedemester Niels Hansen og Hustru Johanne F. Frederiksens Legat" has supported the study.
  
  
  BACKGROUND
  ClinicalTrials.gov registration number: NCT01688778.
authors.affiliation: Department of Endocrinology and Gastroenterology I, Bispebjerg Hospital, Bispebjerg Bakke 23, 2400 Copenhagen NV, Denmark. caroliha@hotmail.com or caroline.raun.hansen@regionh.dk.
authors.forename: Caroline Raun
authors.initials: CR
authors.lastname: Hansen
authors.forename: Hans
authors.initials: H
authors.lastname: Perrild
authors.forename: Birgitte Gade
authors.initials: BG
authors.lastname: Koefoed
authors.forename: Pernille
authors.initials: P
authors.lastname: Faurschou
authors.forename: Dorte
authors.initials: D
authors.lastname: Høst
authors.forename: Mette
authors.initials: M
authors.lastname: Zander
mesh_terms: D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure; D001835:Body Weight; D003404:Creatinine / Q000097:blood; D003718:Denmark; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000628:therapy*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D009043:Motor Activity; D057184:Practice Patterns, Nurses'; D011788:Quality of Life; D012107:Research Design; D017216:Telemedicine; D049269:Videoconferencing; D049629:Waist-Hip Ratio
chemical_list: D001786:Blood Glucose; D003404:Creatinine; D006442:Glycated Hemoglobin; D006454:Hemoglobins; D008055:Lipids; C517652:hemoglobin A1c protein, human